Lobbying activity

Q1

CROSSROADS STRATEGIES, LLC for ALKERMES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income

Pharmacy

View → Q1

K&L GATES, LLP for BORYUNG CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · $10,000.00 income

Aerospace, Pharmacy, Science/Technology

View → Q1

INVARIANT LLC for SK AMERICAS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $140,000.00 income

Taxation/Internal Revenue Code, Trade (domestic/foreign), Energy/Nuclear, Environment/Superfund

View → Q1

CHECKMATE GOVERNMENT RELATIONS for BIOHAVEN LTD.

1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · $80,000.00 income

Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues

View → Q1

BROYDRICK & ASSOCIATES for TONIX PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $20,000.00 income

Pharmacy

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP for KYVERNA THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · $20,000.00 income

Pharmacy

View → Q1

BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY, FORMERLY REPORTED AS, LILLY USA, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · Senate · $90,000.00 income

Pharmacy, Health Issues

View → Q1

SHIONOGI INC. for SHIONOGI INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Insurance

View → Q1

HANCE SCARBOROUGH for ALLIANCE FOR PHARMACY COMPOUNDING

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $50,000.00 income

Health Issues, Pharmacy, Budget/Appropriations

View → 1T

CAPITOL COUNSEL LLC for PCCA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $20,000.00 income

Pharmacy

View → Q1

HANCE SCARBOROUGH for BOEHRINGER INGELHEIM USA CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut · House · Senate · $20,000.00 income

Animals, Pharmacy, Agriculture

View → Q1

FORBES-TATE for PHRMA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income

Health Issues, Medicare/Medicaid, Pharmacy, Consumer Issues/Safety/Products

View → Q1

THORN RUN PARTNERS for OTSUKA AMERICA PHARMACEUTICAL, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $50,000.00 income

Pharmacy, Health Issues, Taxation/Internal Revenue Code

View → Q1

ALBERTSONS COMPANIES, INC. for ALBERTSONS COMPANIES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Idaho · House · Senate

Trade (domestic/foreign), Agriculture, Budget/Appropriations, Computer Industry

View → Q1

CONTINENTAL STRATEGY, LLC for NRX PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · $75,000.00 income

Pharmacy

View → Q1

HIV AND HEPATITIS POLICY INSTITUTE for HIV AND HEPATITIS POLICY INSTITUTE

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Insurance, Pharmacy, Medicare/Medicaid, District of Columbia

View → Q1

W STRATEGIES, LLC for PHLOW CORP.

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $50,000.00 income

Pharmacy

View → Q1

HB STRATEGIES for BAYER U.S. LLC

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $90,000.00 income

Pharmacy, Health Issues, Agriculture

View → Q1

RADIUS ADVOCACY, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income

Copyright/Patent/Trademark, Pharmacy

View → Q1

RADIUS ADVOCACY, LLC for HEALTHCARE DISTRIBUTION ALLIANCE

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · $50,000.00 income

Pharmacy

View → Q1

CONTINENTAL STRATEGY, LLC for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income

Health Issues, Pharmacy

View → Q1

WINNING STRATEGIES WASHINGTON for KALEO

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $20,000.00 income

Health Issues, Pharmacy, Defense, Budget/Appropriations

View → Q1

FEROX STRATEGIES for VIATRIS INC

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $70,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q1

FEROX STRATEGIES for FRESENIUS KABI USA LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $50,000.00 income

Health Issues, Pharmacy, Trade (domestic/foreign)

View → Q1

FEROX STRATEGIES for ELI LILLY AND COMPANY

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy

View →